Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03582046 · ClinicalTrials.gov registry record · NA
Targeting Abdominal Perfusion Pressure in Septic Shock
A NA study, sponsored by Potrero Medical.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03582046 is a NA study that was terminated before completion, run by Potrero Medical. The registered enrollment target is 12 participants.
The verdict
NCT03582046, a NA study, was terminated before completion, sponsored by Potrero Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
A randomized control trial among patients with septic shock, studying the incidence, progression and recovery of AKI.
Interventions
- DEVICE Abdominal Perfusion Pressure (APP)
- DEVICE Mean Arterial Pressure (MAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-02-05 |
| Est. Completion | 2020-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03582046
The ClinicalTrials.gov registry entry for NCT03582046 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Potrero Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Abdominal Perfusion Pressure (APP) is the first listed.
NCT03582046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03582046 about?
NCT03582046 is a clinical study titled "Targeting Abdominal Perfusion Pressure in Septic Shock". A randomized control trial among patients with septic shock, studying the incidence, progression and recovery of AKI.
What is the current status of trial NCT03582046?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2019-02-05. Estimated completion is 2020-06-20.
What interventions are being tested in trial NCT03582046?
The interventions under investigation include: Abdominal Perfusion Pressure (APP) (DEVICE), Mean Arterial Pressure (MAP) (DEVICE).
Who is sponsoring clinical trial NCT03582046?
This trial is sponsored by Potrero Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.